Industry Research Reports
Home > Reports > Service & Software > Global Medication Adherence Software Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Medication Adherence Software Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Service & Software
Published Date: 2025-08-05
Pages: 141 Pages
Report ld: 4849497
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Medication Adherence Software Market Size(US$)
CAGR 2025-2031
7.2%
Market Size,2031
USD 173
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 114 million
Market Forecast in 2031(Value)
US$ 173 million
CAGR
7.2%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Medication Adherence Software market is projected to grow from US$ 105 million in 2024 to US$ 173 million by 2031, at a CAGR of 7.2% (2025-2031), driven by critical product segments and diverse end‑use applications.
Medication adherence software refers to applications or systems used to help patients take medications correctly and on time as directed by their doctors. This type of software improves patients' medication compliance in a variety of ways, thereby improving treatment outcomes and reducing health problems caused by irregular medication. With the development of digital health management, medication adherence software plays an increasingly important role in the healthcare field.
Medication adherence can be defined as the extent to which a person’s behaviour corresponds with taking a medicine optimally. It is key to achieving therapeutic goals and improving patient outcomes. Whereas non-adherence leads to reduced clinical benefit and generates significant waste. As patients' demand for personalized medicine and telehealth services increases, medication adherence software effectively improves medication compliance through functions such as smart reminders, medication tracking, and data synchronization, helping to improve treatment outcomes and reduce medical costs.
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Medication Adherence Software market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- AARDEX Group
- Medisafe
- AdhereHealth
- McKesson
- SMRxT
- Surescripts
- Dosecast
- Agadia Systems
- AiCure
- CleverDev Software
- EnlivenHealth
- AdhereTech
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Cloud-Based
- On-Premises
Segment by Application
- Enterprise
- Medical Institution
- Others
CHAPTER OUTLINE
Chapter 1: Defines the Medication Adherence Software study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Medication Adherence Software: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Medication Adherence Software Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Cloud-Based
1.2.3 On-Premises
1.3 Market Segmentation by Application
1.3.1 Global Medication Adherence Software Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Enterprise
1.3.3 Medical Institution
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Medication Adherence Software Revenue Estimates and Forecasts 2020-2031
2.2 Global Medication Adherence Software Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Medication Adherence Software Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Medication Adherence Software Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Cloud-Based Market Size by Players
3.3.2 On-Premises Market Size by Players
3.4 Global Medication Adherence Software Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Medication Adherence Software Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Medication Adherence Software Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Medication Adherence Software Market Size by Type (2020-2031)
6.4 North America Medication Adherence Software Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Medication Adherence Software Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Medication Adherence Software Market Size by Type (2020-2031)
7.4 Europe Medication Adherence Software Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Medication Adherence Software Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Medication Adherence Software Market Size by Type (2020-2031)
8.4 Asia-Pacific Medication Adherence Software Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Medication Adherence Software Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Medication Adherence Software Market Size by Type (2020-2031)
9.4 Central and South America Medication Adherence Software Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Medication Adherence Software Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Medication Adherence Software Market Size by Type (2020-2031)
10.4 Middle East and Africa Medication Adherence Software Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Medication Adherence Software Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 AARDEX Group
11.1.1 AARDEX Group Corporation Information
11.1.2 AARDEX Group Business Overview
11.1.3 AARDEX Group Medication Adherence Software Product Features and Attributes
11.1.4 AARDEX Group Medication Adherence Software Revenue and Gross Margin (2020-2025)
11.1.5 AARDEX Group Medication Adherence Software Revenue by Product in 2024
11.1.6 AARDEX Group Medication Adherence Software Revenue by Application in 2024
11.1.7 AARDEX Group Medication Adherence Software Revenue by Geographic Area in 2024
11.1.8 AARDEX Group Medication Adherence Software SWOT Analysis
11.1.9 AARDEX Group Recent Developments
11.2 Medisafe
11.2.1 Medisafe Corporation Information
11.2.2 Medisafe Business Overview
11.2.3 Medisafe Medication Adherence Software Product Features and Attributes
11.2.4 Medisafe Medication Adherence Software Revenue and Gross Margin (2020-2025)
11.2.5 Medisafe Medication Adherence Software Revenue by Product in 2024
11.2.6 Medisafe Medication Adherence Software Revenue by Application in 2024
11.2.7 Medisafe Medication Adherence Software Revenue by Geographic Area in 2024
11.2.8 Medisafe Medication Adherence Software SWOT Analysis
11.2.9 Medisafe Recent Developments
11.3 AdhereHealth
11.3.1 AdhereHealth Corporation Information
11.3.2 AdhereHealth Business Overview
11.3.3 AdhereHealth Medication Adherence Software Product Features and Attributes
11.3.4 AdhereHealth Medication Adherence Software Revenue and Gross Margin (2020-2025)
11.3.5 AdhereHealth Medication Adherence Software Revenue by Product in 2024
11.3.6 AdhereHealth Medication Adherence Software Revenue by Application in 2024
11.3.7 AdhereHealth Medication Adherence Software Revenue by Geographic Area in 2024
11.3.8 AdhereHealth Medication Adherence Software SWOT Analysis
11.3.9 AdhereHealth Recent Developments
11.4 McKesson
11.4.1 McKesson Corporation Information
11.4.2 McKesson Business Overview
11.4.3 McKesson Medication Adherence Software Product Features and Attributes
11.4.4 McKesson Medication Adherence Software Revenue and Gross Margin (2020-2025)
11.4.5 McKesson Medication Adherence Software Revenue by Product in 2024
11.4.6 McKesson Medication Adherence Software Revenue by Application in 2024
11.4.7 McKesson Medication Adherence Software Revenue by Geographic Area in 2024
11.4.8 McKesson Medication Adherence Software SWOT Analysis
11.4.9 McKesson Recent Developments
11.5 SMRxT
11.5.1 SMRxT Corporation Information
11.5.2 SMRxT Business Overview
11.5.3 SMRxT Medication Adherence Software Product Features and Attributes
11.5.4 SMRxT Medication Adherence Software Revenue and Gross Margin (2020-2025)
11.5.5 SMRxT Medication Adherence Software Revenue by Product in 2024
11.5.6 SMRxT Medication Adherence Software Revenue by Application in 2024
11.5.7 SMRxT Medication Adherence Software Revenue by Geographic Area in 2024
11.5.8 SMRxT Medication Adherence Software SWOT Analysis
11.5.9 SMRxT Recent Developments
11.6 Surescripts
11.6.1 Surescripts Corporation Information
11.6.2 Surescripts Business Overview
11.6.3 Surescripts Medication Adherence Software Product Features and Attributes
11.6.4 Surescripts Medication Adherence Software Revenue and Gross Margin (2020-2025)
11.6.5 Surescripts Recent Developments
11.7 Dosecast
11.7.1 Dosecast Corporation Information
11.7.2 Dosecast Business Overview
11.7.3 Dosecast Medication Adherence Software Product Features and Attributes
11.7.4 Dosecast Medication Adherence Software Revenue and Gross Margin (2020-2025)
11.7.5 Dosecast Recent Developments
11.8 Agadia Systems
11.8.1 Agadia Systems Corporation Information
11.8.2 Agadia Systems Business Overview
11.8.3 Agadia Systems Medication Adherence Software Product Features and Attributes
11.8.4 Agadia Systems Medication Adherence Software Revenue and Gross Margin (2020-2025)
11.8.5 Agadia Systems Recent Developments
11.9 AiCure
11.9.1 AiCure Corporation Information
11.9.2 AiCure Business Overview
11.9.3 AiCure Medication Adherence Software Product Features and Attributes
11.9.4 AiCure Medication Adherence Software Revenue and Gross Margin (2020-2025)
11.9.5 AiCure Recent Developments
11.10 CleverDev Software
11.10.1 CleverDev Software Corporation Information
11.10.2 CleverDev Software Business Overview
11.10.3 CleverDev Software Medication Adherence Software Product Features and Attributes
11.10.4 CleverDev Software Medication Adherence Software Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 EnlivenHealth
11.11.1 EnlivenHealth Corporation Information
11.11.2 EnlivenHealth Business Overview
11.11.3 EnlivenHealth Medication Adherence Software Product Features and Attributes
11.11.4 EnlivenHealth Medication Adherence Software Revenue and Gross Margin (2020-2025)
11.11.5 EnlivenHealth Recent Developments
11.12 AdhereTech
11.12.1 AdhereTech Corporation Information
11.12.2 AdhereTech Business Overview
11.12.3 AdhereTech Medication Adherence Software Product Features and Attributes
11.12.4 AdhereTech Medication Adherence Software Revenue and Gross Margin (2020-2025)
11.12.5 AdhereTech Recent Developments
12 Medication Adherence SoftwareIndustry Chain Analysis
12.1 Medication Adherence Software Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Medication Adherence Software Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Medication Adherence Software Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Medication Adherence Software Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Medication Adherence Software Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Medication Adherence Software Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Medication Adherence Software Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Medication Adherence Software Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Medication Adherence Software Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Medication Adherence Software Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Medication Adherence Software by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medication Adherence Software as of 2024)
Table 11. Global Medication Adherence Software Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Medication Adherence Software Companies Headquarters
Table 13. Global Medication Adherence Software Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Medication Adherence Software Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Medication Adherence Software Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Medication Adherence Software Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Medication Adherence Software Revenue by Application (2026-2031) & (US$ Million)
Table 21. Medication Adherence Software High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Medication Adherence Software Growth Accelerators and Market Barriers
Table 25. North America Medication Adherence Software Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Medication Adherence Software Growth Accelerators and Market Barriers
Table 27. Europe Medication Adherence Software Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Medication Adherence Software Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Medication Adherence Software Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Medication Adherence Software Investment Opportunities and Key Challenges
Table 31. Central and South America Medication Adherence Software Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Medication Adherence Software Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Medication Adherence Software Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. AARDEX Group Corporation Information
Table 35. AARDEX Group Description and Major Businesses
Table 36. AARDEX Group Product Features and Attributes
Table 37. AARDEX Group Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. AARDEX Group Revenue Proportion by Product in 2024
Table 39. AARDEX Group Revenue Proportion by Application in 2024
Table 40. AARDEX Group Revenue Proportion by Geographic Area in 2024
Table 41. AARDEX Group Medication Adherence Software SWOT Analysis
Table 42. AARDEX Group Recent Developments
Table 43. Medisafe Corporation Information
Table 44. Medisafe Description and Major Businesses
Table 45. Medisafe Product Features and Attributes
Table 46. Medisafe Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Medisafe Revenue Proportion by Product in 2024
Table 48. Medisafe Revenue Proportion by Application in 2024
Table 49. Medisafe Revenue Proportion by Geographic Area in 2024
Table 50. Medisafe Medication Adherence Software SWOT Analysis
Table 51. Medisafe Recent Developments
Table 52. AdhereHealth Corporation Information
Table 53. AdhereHealth Description and Major Businesses
Table 54. AdhereHealth Product Features and Attributes
Table 55. AdhereHealth Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. AdhereHealth Revenue Proportion by Product in 2024
Table 57. AdhereHealth Revenue Proportion by Application in 2024
Table 58. AdhereHealth Revenue Proportion by Geographic Area in 2024
Table 59. AdhereHealth Medication Adherence Software SWOT Analysis
Table 60. AdhereHealth Recent Developments
Table 61. McKesson Corporation Information
Table 62. McKesson Description and Major Businesses
Table 63. McKesson Product Features and Attributes
Table 64. McKesson Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. McKesson Revenue Proportion by Product in 2024
Table 66. McKesson Revenue Proportion by Application in 2024
Table 67. McKesson Revenue Proportion by Geographic Area in 2024
Table 68. McKesson Medication Adherence Software SWOT Analysis
Table 69. McKesson Recent Developments
Table 70. SMRxT Corporation Information
Table 71. SMRxT Description and Major Businesses
Table 72. SMRxT Product Features and Attributes
Table 73. SMRxT Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. SMRxT Revenue Proportion by Product in 2024
Table 75. SMRxT Revenue Proportion by Application in 2024
Table 76. SMRxT Revenue Proportion by Geographic Area in 2024
Table 77. SMRxT Medication Adherence Software SWOT Analysis
Table 78. SMRxT Recent Developments
Table 79. Surescripts Corporation Information
Table 80. Surescripts Description and Major Businesses
Table 81. Surescripts Product Features and Attributes
Table 82. Surescripts Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. Surescripts Recent Developments
Table 84. Dosecast Corporation Information
Table 85. Dosecast Description and Major Businesses
Table 86. Dosecast Product Features and Attributes
Table 87. Dosecast Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. Dosecast Recent Developments
Table 89. Agadia Systems Corporation Information
Table 90. Agadia Systems Description and Major Businesses
Table 91. Agadia Systems Product Features and Attributes
Table 92. Agadia Systems Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. Agadia Systems Recent Developments
Table 94. AiCure Corporation Information
Table 95. AiCure Description and Major Businesses
Table 96. AiCure Product Features and Attributes
Table 97. AiCure Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. AiCure Recent Developments
Table 99. CleverDev Software Corporation Information
Table 100. CleverDev Software Description and Major Businesses
Table 101. CleverDev Software Product Features and Attributes
Table 102. CleverDev Software Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. CleverDev Software Recent Developments
Table 104. EnlivenHealth Corporation Information
Table 105. EnlivenHealth Description and Major Businesses
Table 106. EnlivenHealth Product Features and Attributes
Table 107. EnlivenHealth Revenue (US$ Million) and Gross Margin (2020-2025)
Table 108. EnlivenHealth Recent Developments
Table 109. AdhereTech Corporation Information
Table 110. AdhereTech Description and Major Businesses
Table 111. AdhereTech Product Features and Attributes
Table 112. AdhereTech Revenue (US$ Million) and Gross Margin (2020-2025)
Table 113. AdhereTech Recent Developments
Table 114. Raw Materials Key Suppliers
Table 115. Distributors List
Table 116. Market Trends and Market Evolution
Table 117. Market Drivers and Opportunities
Table 118. Market Challenges, Risks, and Restraints
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Medication Adherence Software Product Picture
Figure 2. Global Medication Adherence Software Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Cloud-Based Product Picture
Figure 4. On-Premises Product Picture
Figure 5. Global Medication Adherence Software Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Enterprise
Figure 7. Medical Institution
Figure 8. Others
Figure 9. Medication Adherence Software Report Years Considered
Figure 10. Global Medication Adherence Software Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Medication Adherence Software Revenue (2020-2031) & (US$ Million)
Figure 12. Global Medication Adherence Software Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 13. Global Medication Adherence Software Revenue Market Share by Region (2020-2031)
Figure 14. Global Medication Adherence Software Revenue Market Share Ranking (2024)
Figure 15. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 16. Cloud-Based Revenue Market Share by Player in 2024
Figure 17. On-Premises Revenue Market Share by Player in 2024
Figure 18. Global Medication Adherence Software Revenue Market Share by Type (2020-2031)
Figure 19. Global Medication Adherence Software Revenue Market Share by Application (2020-2031)
Figure 20. North America Medication Adherence Software Revenue YoY (2020-2031) & (US$ Million)
Figure 21. North America Top 5 Players Medication Adherence Software Revenue (US$ Million) in 2024
Figure 22. North America Medication Adherence Software Revenue (US$ Million) by Type (2020 - 2031)
Figure 23. North America Medication Adherence Software Revenue (US$ Million) by Application (2020-2031)
Figure 24. US Medication Adherence Software Revenue (2020-2031) & (US$ Million)
Figure 25. Canada Medication Adherence Software Revenue (2020-2031) & (US$ Million)
Figure 26. Mexico Medication Adherence Software Revenue (2020-2031) & (US$ Million)
Figure 27. Europe Medication Adherence Software Revenue YoY (2020-2031) & (US$ Million)
Figure 28. Europe Top 5 Players Medication Adherence Software Revenue (US$ Million) in 2024
Figure 29. Europe Medication Adherence Software Revenue (US$ Million) by Type (2020-2031)
Figure 30. Europe Medication Adherence Software Revenue (US$ Million) by Application (2020-2031)
Figure 31. Germany Medication Adherence Software Revenue (2020-2031) & (US$ Million)
Figure 32. France Medication Adherence Software Revenue (2020-2031) & (US$ Million)
Figure 33. U.K. Medication Adherence Software Revenue (2020-2031) & (US$ Million)
Figure 34. Italy Medication Adherence Software Revenue (2020-2031) & (US$ Million)
Figure 35. Russia Medication Adherence Software Revenue (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Medication Adherence Software Revenue YoY (2020-2031) & (US$ Million)
Figure 37. Asia-Pacific Top 8 Players Medication Adherence Software Revenue (US$ Million) in 2024
Figure 38. Asia-Pacific Medication Adherence Software Revenue (US$ Million) by Type (2020-2031)
Figure 39. Asia-Pacific Medication Adherence Software Revenue (US$ Million) by Application (2020-2031)
Figure 40. Indonesia Medication Adherence Software Revenue (2020-2031) & (US$ Million)
Figure 41. Japan Medication Adherence Software Revenue (2020-2031) & (US$ Million)
Figure 42. South Korea Medication Adherence Software Revenue (2020-2031) & (US$ Million)
Figure 43. Australia Medication Adherence Software Revenue (2020-2031) & (US$ Million)
Figure 44. India Medication Adherence Software Revenue (2020-2031) & (US$ Million)
Figure 45. Indonesia Medication Adherence Software Revenue (2020-2031) & (US$ Million)
Figure 46. Vietnam Medication Adherence Software Revenue (2020-2031) & (US$ Million)
Figure 47. Malaysia Medication Adherence Software Revenue (2020-2031) & (US$ Million)
Figure 48. Philippines Medication Adherence Software Revenue (2020-2031) & (US$ Million)
Figure 49. Singapore Medication Adherence Software Revenue (2020-2031) & (US$ Million)
Figure 50. Central and South America Medication Adherence Software Revenue YoY (2020-2031) & (US$ Million)
Figure 51. Central and South America Top 5 Players Medication Adherence Software Revenue (US$ Million) in 2024
Figure 52. Central and South America Medication Adherence Software Revenue (US$ Million) by Type (2020-2031)
Figure 53. Central and South America Medication Adherence Software Revenue (US$ Million) by Application (2020-2031)
Figure 54. Brazil Medication Adherence Software Revenue (2020-2025) & (US$ Million)
Figure 55. Argentina Medication Adherence Software Revenue (2020-2025) & (US$ Million)
Figure 56. Middle East and Africa Medication Adherence Software Revenue YoY (2020-2031) & (US$ Million)
Figure 57. Middle East and Africa Top 5 Players Medication Adherence Software Revenue (US$ Million) in 2024
Figure 58. South America Medication Adherence Software Revenue (US$ Million) by Type (2020-2031)
Figure 59. Middle East and Africa Medication Adherence Software Revenue (US$ Million) by Application (2020-2031)
Figure 60. GCC Countries Medication Adherence Software Revenue (2020-2025) & (US$ Million)
Figure 61. Israel Medication Adherence Software Revenue (2020-2025) & (US$ Million)
Figure 62. Egypt Medication Adherence Software Revenue (2020-2025) & (US$ Million)
Figure 63. South Africa Medication Adherence Software Revenue (2020-2025) & (US$ Million)
Figure 64. Medication Adherence Software Industry Chain Mapping
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Medication Adherence Software in 2031?
The global market size of Medication Adherence Software in 2031 was 173 Million USD.
Which companies rank high in the global Medication Adherence Software market?
What is the annual compound growth rate of the global Medication Adherence Software market size from 2025 to 2031?
Which region is expected to have the highest market share?
What was the global market size of Medication Adherence Software in 2025?
Related Reports
Global Medication Adherence Software Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Medication Adherence Software market is projected to grow from US$ 114 million in 2025 to US$ 184 million by 2032, at a CAGR of 7.2% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-26
Pages: 137
USD 4900.00
(Single User License)
Global Medication Adherence Software Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Medication Adherence Software market size was US$ 114 million in 2025 and is forecast to reach a readjusted size of US$ 184 million by 2032 with a CAGR of 7.2% during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 91
USD 4250.00
(Single User License)
Medication Adherence Software - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Medication Adherence Software was estimated to be worth US$ 114 million in 2025 and is projected to reach US$ 184 million, growing at a CAGR of 7.2% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 118
USD 3950.00
(Single User License)
Global Medication Adherence Software Market Research Report 2026
The global Medication Adherence Software market was valued at US$ 114 million in 2025 and is anticipated to reach US$ 184 million by 2032, at a CAGR of 7.2% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 111
USD 2900.00
(Single User License)
Global Medication Adherence Software Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Medication Adherence Software market size was US$ 105 million in 2024 and is forecast to a readjusted size of US$ 173 million by 2031 with a CAGR of 7.2% during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 94
USD 4250.00
(Single User License)
Global Medication Adherence Software Market Insights, Forecast to 2031
The global Medication Adherence Software market is projected to grow from US$ 114 million in 2025 to US$ 173 million by 2031, at a Compound Annual Growth Rate (CAGR) of 7.2% during the forecast period.
Published Date: 2025-06-20
Pages: 138
USD 4900.00
(Single User License)
Medication Adherence Software - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Medication Adherence Software was estimated to be worth US$ 105 million in 2024 and is forecast to a readjusted size of US$ 173 million by 2031 with a CAGR of 7.2% during the forecast period 2025-2031.
Published Date: 2025-06-20
Pages: 117
USD 3950.00
(Single User License)
Global Medication Adherence Software Market Research Report 2025
The global market for Medication Adherence Software was valued at US$ 105 million in the year 2024 and is projected to reach a revised size of US$ 173 million by 2031, growing at a CAGR of 7.2% during the forecast period.
Published Date: 2025-06-20
Pages: 81
USD 2900.00
(Single User License)
Global and United States Medication Adherence Software Market Report & Forecast 2024-2030
Medication Adherence Software is a tool used to help patients take their medications on time and correctly. It typically includes reminder features, recording functions, and educational resources. By using Medication Adherence Software, patients can better manage their medication plans, improve treatment outcomes, and reduce the risk of side effects.
Published Date: 2024-10-22
Pages: 93
USD 4350.00
(Single User License)
Global Medication Adherence Software Market Insights, Forecast to 2030
Medication Adherence Software is a tool used to help patients take their medications on time and correctly. It typically includes reminder features, recording functions, and educational resources. By using Medication Adherence Software, patients can better manage their medication plans, improve treatment outcomes, and reduce the risk of side effects.
Published Date: 2024-10-22
Pages: 121
USD 4900.00
(Single User License)
Global Medication Adherence Software Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Medication Adherence Software market is projected to grow from US$ 114 million in 2025 to US$ 184 million by 2032, at a CAGR of 7.2% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-26
Pages: 137
USD 4900.00 (Single User License)Global Medication Adherence Software Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Medication Adherence Software market size was US$ 114 million in 2025 and is forecast to reach a readjusted size of US$ 184 million by 2032 with a CAGR of 7.2% during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 91
USD 4250.00 (Single User License)Medication Adherence Software - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Medication Adherence Software was estimated to be worth US$ 114 million in 2025 and is projected to reach US$ 184 million, growing at a CAGR of 7.2% from 2026 to 2032.
Published: 2026-01-08
Pages: 118
USD 3950.00 (Single User License)Global Medication Adherence Software Market Research Report 2026
The global Medication Adherence Software market was valued at US$ 114 million in 2025 and is anticipated to reach US$ 184 million by 2032, at a CAGR of 7.2% from 2026 to 2032.
Published: 2026-01-08
Pages: 111
USD 2900.00 (Single User License)Global Medication Adherence Software Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Medication Adherence Software market size was US$ 105 million in 2024 and is forecast to a readjusted size of US$ 173 million by 2031 with a CAGR of 7.2% during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 94
USD 4250.00 (Single User License)Global Medication Adherence Software Market Insights, Forecast to 2031
The global Medication Adherence Software market is projected to grow from US$ 114 million in 2025 to US$ 173 million by 2031, at a Compound Annual Growth Rate (CAGR) of 7.2% during the forecast period.
Published: 2025-06-20
Pages: 138
USD 4900.00 (Single User License)Medication Adherence Software - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Medication Adherence Software was estimated to be worth US$ 105 million in 2024 and is forecast to a readjusted size of US$ 173 million by 2031 with a CAGR of 7.2% during the forecast period 2025-2031.
Published: 2025-06-20
Pages: 117
USD 3950.00 (Single User License)Global Medication Adherence Software Market Research Report 2025
The global market for Medication Adherence Software was valued at US$ 105 million in the year 2024 and is projected to reach a revised size of US$ 173 million by 2031, growing at a CAGR of 7.2% during the forecast period.
Published: 2025-06-20
Pages: 81
USD 2900.00 (Single User License)Global and United States Medication Adherence Software Market Report & Forecast 2024-2030
Medication Adherence Software is a tool used to help patients take their medications on time and correctly. It typically includes reminder features, recording functions, and educational resources. By using Medication Adherence Software, patients can better manage their medication plans, improve treatment outcomes, and reduce the risk of side effects.
Published: 2024-10-22
Pages: 93
USD 4350.00 (Single User License)Global Medication Adherence Software Market Insights, Forecast to 2030
Medication Adherence Software is a tool used to help patients take their medications on time and correctly. It typically includes reminder features, recording functions, and educational resources. By using Medication Adherence Software, patients can better manage their medication plans, improve treatment outcomes, and reduce the risk of side effects.
Published: 2024-10-22
Pages: 121
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now